Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Multicenter, 16-week Study to Evaluate the Efficacy and Safety of Two Prescription Digital Therapeutics as an Adjunct to Standard-of-Care Antipsychotic Therapy in Adult and Late Adolescent Participants With Experiential Negative Symptoms of Schizophrenia

NCT05838625 is registered in ClinicalTrials.gov with Click Therapeutics, Inc. as lead sponsor.

NCT NCT05838625
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05838625 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Multicenter, 16-week Study to Evaluate the Efficacy and Safety of Two Prescription Digital Therapeutics as an Adjunct to Standard-of-Care Antipsychotic Therapy in Adult and Late Adolescent Participants With Experiential Negative Symptoms of Schizophrenia
Lead sponsor
Click Therapeutics, Inc.
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2023
Completion date
July 23, 2025
Enrollment
464 (actual)
Sites
54

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia